Greg Malnassy

899 total citations
10 papers, 254 citations indexed

About

Greg Malnassy is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Greg Malnassy has authored 10 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Greg Malnassy's work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Greg Malnassy is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Greg Malnassy collaborates with scholars based in United States, Australia and Egypt. Greg Malnassy's co-authors include Wendy Stock, Richard A. Larson, Wei Qiu, Frederick R. Appelbaum, Elisabeth Paietta, Suzanne Kamel‐Reid, Jerald P. Radich, Brian Druker, Martha Wadleigh and Kenneth J. Kopecky and has published in prestigious journals such as Blood, Gastroenterology and Frontiers in Oncology.

In The Last Decade

Greg Malnassy

10 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Malnassy United States 6 143 118 75 73 63 10 254
Patricia Martin‐Regueira United States 9 332 2.3× 206 1.7× 99 1.3× 123 1.7× 67 1.1× 21 464
Emilia Scalzulli Italy 10 271 1.9× 159 1.3× 52 0.7× 90 1.2× 28 0.4× 60 358
Maryse Power Canada 12 232 1.6× 168 1.4× 71 0.9× 132 1.8× 54 0.9× 44 384
P Shepherd United Kingdom 8 329 2.3× 259 2.2× 159 2.1× 35 0.5× 71 1.1× 15 388
Chang‐Liang Lai Taiwan 7 347 2.4× 161 1.4× 22 0.3× 28 0.4× 108 1.7× 10 408
Márcia Torresan Delamain Brazil 10 139 1.0× 126 1.1× 68 0.9× 69 0.9× 38 0.6× 53 272
Jimmie H. Harvey United States 6 115 0.8× 144 1.2× 51 0.7× 49 0.7× 11 0.2× 9 285
J. Janssen Netherlands 9 285 2.0× 222 1.9× 111 1.5× 70 1.0× 49 0.8× 11 412
Ute Apfelbeck Austria 6 132 0.9× 116 1.0× 61 0.8× 36 0.5× 10 0.2× 8 236
Nataliia Glushko Ukraine 2 275 1.9× 217 1.8× 120 1.6× 77 1.1× 34 0.5× 2 327

Countries citing papers authored by Greg Malnassy

Since Specialization
Citations

This map shows the geographic impact of Greg Malnassy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Malnassy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Malnassy more than expected).

Fields of papers citing papers by Greg Malnassy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Malnassy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Malnassy. The network helps show where Greg Malnassy may publish in the future.

Co-authorship network of co-authors of Greg Malnassy

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Malnassy. A scholar is included among the top collaborators of Greg Malnassy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Malnassy. Greg Malnassy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Malnassy, Greg, et al.. (2024). The Integrated Stress Response in Pancreatic Development, Tissue Homeostasis, and Cancer. Gastroenterology. 167(7). 1292–1306. 4 indexed citations
2.
Malnassy, Greg, Wei Hou, Scott J. Cotler, et al.. (2023). Inhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression. Cellular and Molecular Gastroenterology and Hepatology. 16(5). 685–709. 5 indexed citations
3.
Hou, Wei, et al.. (2022). Integrin subunit beta 8 contributes to lenvatinib resistance in HCC. Hepatology Communications. 6(7). 1786–1802. 39 indexed citations
4.
Wang, Fang, Greg Malnassy, & Wei Qiu. (2021). The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 653037–653037. 11 indexed citations
5.
Fulton, Noreen, Jeffrey Johnson, Lawrence D. Kaplan, et al.. (2013). Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance). Blood. 122(21). 3002–3002. 2 indexed citations
7.
Radich, Jerald P., Kenneth J. Kopecky, Frederick R. Appelbaum, et al.. (2012). A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia. Blood. 120(19). 3898–3905. 132 indexed citations
8.
Liu, Hongtao, Jeffrey Johnson, Greg Malnassy, et al.. (2011). *701 Detection of Minimal Residual Disease Following Induction Immunochemotherapy Predicts Progression Free Survival in Mantle Cell Lymphoma: Final Results of CALGB 59909. Clinical Lymphoma Myeloma & Leukemia. 11. S130–S131. 6 indexed citations
9.
Liu, Hongtao, Ernesto Díaz-Flores, Xavier Poiré, et al.. (2010). Combination of a MEK Inhibitor, AZD6244, and Dual PI3K/mTOR Inhibitor, NVP-BEZ235: An Effective Therapeutic Strategy for Acute Myeloid Leukemia. Blood. 116(21). 3978–3978. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026